-
Generating and Characterizing LRRK2 Antibodies
… normal and Parkinson’s cellular function. MJFF is funding multiple groups to develop therapies against LRRK2 that, if … selection of one or several antibodies that perform well in multiple different methodologies, and these will then be …
-
Preclinical Efficacy and Biomarker Development for a Clinical Stage Inhibitor of Lipid Metabolism in Parkinson’s Disease
… that inhibits SCD. In this study, we will test YTX-7739 in multiple preclinical models that differ in how … reveal how YTX-7739 affects alpha-synuclein toxicity in multiple brain cell types and how people with PD may best …
-
Evaluation of Digital Mobility Data to Identify Individuals at Risk of Developing Parkinson’s Disease
… technology provides accurate, sensitive assessment of multiple, disparate mobility functions, both in controlled … technology, which is capable of accurately capturing multiple mobility functions. Development of these …
-
Carolyn Schenker
… very involved at the Riverdale Country School, as well as multiple charities. She currently lives in New York with her …
-
MJFF Awardee to Study Drug with Potential to Treat Dyskinesia
October 24, 2012
… AVP-923 is also currently in development to treat multiple sclerosis. Nate Herpich …
-
An Energizing Experience: Recapping the Movement Disorder Society’s (MDS) International Congress
July 9, 2012
… it. But now we see it affects so much more than the motor system,” he says. He also noted how much the field of … and people want our opinion.” Having attended the congress multiple times before, Maurizio had already made a number of …